HEALTH-2007-2.2.1-7
HEALTH-2007-2.2.1-7
6 projects · €27,253,906 total EU contribution (project-level) · 64 participating organizations · 14 countries with participants
Total EU funding
Sum of EC max contribution fields for distinct projects in this topic.
€27,253,906
Countries active
Participant organizations by country (headquarters in CORDIS).
- Germany (13)
- France (11)
- UK (8)
- CH (6)
- Italy (4)
- BE (3)
- FI (3)
- Netherlands (3)
- SE (3)
- Spain (2)
- HU (2)
- IL (2)
- PL (2)
- EE (1)
Open calls
From the EU Funding & Tenders Portal, linked to this topic code when it matches the call identifier. Sync via yarn etl:funding.
No open or forthcoming calls linked to this topic in the database yet.
Top organizations
By number of distinct projects in this topic.
- KU Leuven3 projects · BE
- UNIVERSITY COLLEGE LONDON3 projects · —
- CARDIFF UNIVERSITY2 projects · UK
- CRL2 projects · FI
- HELSINGIN YLIOPISTO2 projects · FI
- MPG2 projects · DE
- Actar1 projects · SE
- ASSISTANCE PUBLIQUE HOPITAUX DE PARIS1 projects · FR
- EPDA1 projects · BE
- BIOSYNTH BV1 projects · NL
- CHU LILLE1 projects · FR
- CHU LIMOGES1 projects · FR
Projects
Page 1 of 1
| Project | Programme | EU contribution | Total cost | |
|---|---|---|---|---|
Promotion of plasticity as a treatment for neurodegenerative conditions PLASTICISE · 223524 | FP7 | €5,199,445 | €6,767,728 | Details |
Restorative Plasticity At Corticostriatal Excitatory Synapses REPLACES · 222918 | FP7 | €4,219,766 | €5,454,740 | Details |
Mitochondrial dysfunction in neurodegenerative diseases: towards new therapeutics MITOTARGET · 223388 | FP7 | €5,999,980 | €10,332,038 | Details |
GSK-3 in neuronal plasticity and neurodegeneration: basic mechanisms and pre-clinical assessment. NEURO.GSK3 · 223276 | FP7 | €3,573,842 | €5,082,027 | Details |
OLIGOPEPTIDASE INHIBITORS IN BRAIN FUNCTION AND DYSFUNCTION: TOWARDS NEW THERAPEUTIC STRATEGIES FOR NEUROPROTECTION NEUROPRO · 223077 | FP7 | €4,788,220 | €6,290,178 | Details |
Molecular mechanisms of neuronal restoration: novel approaches for Parkinson's Disease MOLPARK · 223489 | FP7 | €3,472,653 | €4,590,740 | Details |